CCR7+ dendritic cells expressing both IL-23A and IL-12B potentially contribute to psoriasis relapse
Abstract Interleukin (IL)−23 is the master pathogenic cytokine in psoriasis and neutralization of IL-23 alleviates psoriasis. Psoriasis relapses after the withdrawal of anti-IL-23 antibodies, and the persistence of IL-23-producing cells potentially contributes to such recurrence, but the cellular so...
Saved in:
| Main Authors: | Yang Sun, Fangzhou Lou, Xiaojie Cai, Zhikai Wang, Xiuli Yang, Libo Sun, Zhenyao Xu, Siyu Deng, Zhouwei Wu, Zhaoyuan Liu, Yu-Ling Shi, Florent Ginhoux, Honglin Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-62874-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RIG‐I antiviral signaling drives interleukin‐23 production and psoriasis‐like skin disease
by: Huiyuan Zhu, et al.
Published: (2017-04-01) -
IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma
by: Xiaoying Hu, et al.
Published: (2020-10-01) -
Beyond CCR7: dendritic cell migration in type 2 inflammation
by: Audrey Meloun, et al.
Published: (2025-02-01) -
Immune subversion by Mycobacterium tuberculosis through CCR5 mediated signaling: involvement of IL-10.
by: Shibali Das, et al.
Published: (2014-01-01) -
IL-17 and IL-23 Inhibitors in Moderate to Severe Plaque Psoriasis as Part of Current Therapeutic Strategies
by: Ieva Saulite, et al.
Published: (2024-07-01)